| Product Code: ETC7657857 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s import of oral hypoglycemic agents (OHAs) in 2024 saw top shipments coming from Switzerland, UK, Belgium, USA, and Germany. Despite the low Herfindahl-Hirschman Index (HHI) indicating low market concentration, the compound annual growth rate (CAGR) for the period 2020-2024 was -2.14%. Furthermore, the growth rate from 2023 to 2024 stood at -0.41%, highlighting a slight decline in import volumes. These trends suggest a stable but slightly declining market for oral hypoglycemic agents in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Israel Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2022 & 2032F |
3.6 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2022 & 2032F |
4 Israel Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing awareness about the importance of managing diabetes |
4.2.3 Technological advancements in oral hypoglycemic agents |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for new oral hypoglycemic agents |
4.3.2 High cost associated with some oral hypoglycemic agents |
4.3.3 Competition from alternative treatment methods such as insulin therapy |
5 Israel Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Israel Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Israel Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2022 - 2032F |
6.1.3 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2022 - 2032F |
6.1.4 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.1.5 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2022 - 2032F |
6.1.6 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2022 - 2032F |
6.2 Israel Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2022 - 2032F |
6.2.3 Israel Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2022 - 2032F |
7 Israel Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Israel Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Israel Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Israel Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed oral hypoglycemic agents |
8.2 Rate of new product launches in the oral hypoglycemic agents market |
8.3 Number of clinical trials and research studies on oral hypoglycemic agents |
8.4 Adoption rate of digital health solutions for diabetes management |
8.5 Percentage of healthcare professionals recommending oral hypoglycemic agents as first-line treatment for diabetes |
9 Israel Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Israel Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2022 & 2032F |
9.2 Israel Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2022 & 2032F |
10 Israel Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Israel Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2025 |
10.2 Israel Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here